二氧化碳專用凈化裝置 2020年版《中華人民共和國藥典》

藥品注冊標準收載檢驗項目少于藥典規(guī)定或質量指標低于藥典要求的

浩瀚色譜（山東）應用技術開發(fā)有限公司以振興民族企業(yè)為己任

2020年版《中華人民共和國藥典》 測試譜圖：


The 2020 edition of the Pharmacopoeia of the People's Republic of China
The 2020 edition of "The Pharmacopoeia of the People's Republic of China" Details:

Name: Pharmacopoeia carbon dioxide (CO2) purification device

Model: HHO-III Purification device

Application: 2020 and 2015 Chinese Pharmacopoeia Determination of Hydrocarbons in Carbon Dioxide Gas Chromatography


The 2020 edition of the "Pharmacopoeia of the People's Republic of China" (hereinafter referred to as the "Chinese Pharmacopoeia") has been issued by the National Medical Products Administration and National Health Commission Announcement No. 78, 2020, and will be implemented on December 30, 2020. The relevant matters concerning the implementation of this edition of the Chinese Pharmacopoeia are hereby announced as follows:

1. According to the provisions of the "Drug Administration Law", drugs should comply with national drug standards. The "Chinese Pharmacopoeia" is an important part of the national drug standards, and is a legal technical standard that should be followed by relevant units such as drug research and development, production (import), operation, use, supervision and management.

2. The "Chinese Pharmacopoeia" mainly consists of legends, variety texts and general technical requirements. From the date of implementation, all drugs produced and marketed shall meet the relevant technical requirements of this edition of the Chinese Pharmacopoeia.

3. From the date of implementation, all varieties that were originally included in the pharmacopoeias of the calendar and the standards issued by the bureaus (ministries), and those included in this edition of the Chinese Pharmacopoeia, the corresponding pharmacopoeias and the standards issued by the bureaus (ministers) shall be abolished simultaneously; If this edition of the "Chinese Pharmacopoeia" is not included, the corresponding historical editions of the pharmacopoeia and bureau (ministerial) standards shall still be implemented, but should comply with the relevant general technical requirements of this edition of the "Chinese Pharmacopoeia". Corresponding historical editions of the pharmacopoeia, bureau (minister) issued standards are abolished.

The quality standards of preparation specifications and preparation methods of traditional Chinese medicines that are not included in the text of this edition of the Chinese Pharmacopoeia shall be implemented in accordance with the relevant requirements of the same variety in this edition of the Chinese Pharmacopoeia, and specifications and preparation items shall be implemented in accordance with the original approval documents.

4. If the drug registration standard contains more inspection items than or different from the pharmacopoeia, or the quality index is stricter than the pharmacopoeia requirements, the corresponding items and indicators of the registration standard shall be implemented on the basis of the pharmacopoeia requirements.

If the inspection items included in the drug registration standards are less than the pharmacopoeia regulations or the quality index is lower than the pharmacopoeia requirements, the pharmacopoeia regulations shall be implemented.





Haohan Chromatography (Shandong) Applied Technology Development Co., Ltd. takes the revitalization of national enterprises as its mission. According to the requirements stipulated in the 2020 Chinese Pharmacopoeia for carbon dioxide: the content of hydrocarbons is not more than 0.0020%, the HHO-III Purification device has been upgraded and transformed. , And named the 2021 NEW model, this device is more in line with the 2020 version of the Pharmacopoeia, with good purification effect, accurate and reliable quantification.

Haohan Chromatography provides detailed operation methods and installation drawings.


The test spectrum of the 2020 edition of "The Pharmacopoeia of People's Republic of China"